Information on safety, labeling changes, and pharmaceutical research
Search results for: liver
Patient Self-Management Pioneer
Kate Lorig RN, DrPH, continues to map new territories
A New Breed of Practice
As small practice physicians are forced to combat increasing overhead and shriveling reimbursement, we seem to be entering an era of medical practice Darwinism—survival of those that are most fit to operate in today’s severe and unforgiving healthcare environment.
Quality Advice from Specialty Societies
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies
Meet the HEP C Challenge
Keep a hepatitis C virus infection from hindering RA treatment
Cellular Therapy of Autoimmune Disease
Is a novel treatment breakthrough on the horizon?
Rheum to Learn
The ARHP’s new NP/PA rheumatology training program will provide a boost to the workforce
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.
Why the REF?
I am delighted to use the occasion of this inaugural REF president’s column to share a vision of the future and describe the exciting developments that will allow us to meet the challenges ahead. Although most of you know that the ACR is associated with a foundation, I find that many of our members wonder what the REF does that is different from the mission and activities of the ACR and the ARHP. In the simplest terms, the ACR and the ARHP are engaged in improving the quality of our professional lives as rheumatologists and rheumatology health professionals, while the core mission of the REF is to ensure the future of our specialty.
ACR Publishes New Guide for RA Care
Updated guidelines synthesize and formalize recommendations for DMARD use
- « Previous Page
- 1
- …
- 120
- 121
- 122
- 123
- 124
- …
- 127
- Next Page »